Bunkerhill AVC vs FFRangio System

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Bunkerhill AVC

by BunkerHill Health

FFRangio System

by CathWorks (acquired by Medtronic)

AI Verdict

Tool A focuses on leveraging generative AI for automated detection and quantification of various calcifications and bone density from CT scans, aiding in early diagnosis and clinical reasoning. Tool B, conversely, provides wire-free and drug-free 3D FFR guidance during interventional procedures, optimizing PCI decisions for coronary artery disease using real-time angiogram analysis. While both utilize AI in cardiology, their applications target distinct stages of patient care—diagnostic imaging analysis versus interventional procedure guidance.

Choose Bunkerhill AVC if…

Choose Bunkerhill AVC if your health system aims to leverage existing chest CT scans for opportunistic, automated screening and quantification of multiple cardiac calcifications (aortic, coronary, mitral annular) and bone density. This tool is ideal for improving patient outcomes through early detection and automating workflows by integrating seamlessly with your EHR and clinical archives.

View Bunkerhill AVC →

Choose FFRangio System if…

Choose FFRangio System if your cath lab seeks to optimize percutaneous coronary intervention (PCI) decisions with real-time, wire-free, and drug-free fractional flow reserve (FFR) guidance. This system is best suited for providing accurate multi-vessel FFR results and advanced insights directly within the cath lab environment to quickly confirm and refine treatment strategies for coronary artery disease.

View FFRangio System →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Bunkerhill AVC	FFRangio System
Pricing	Contact for pricing	Contact vendor for pricing information.
Deployment	Integrates with full Electronic Health Records (EHRs) and clinical archives within health systems.	SaaS, on-prem, hybrid
BAA Available	Unknown	Yes AI-estimated
FDA Status	1 AI-estimated	1 AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Bunkerhill AVC

Tool A, Bunkerhill AVC, offers broader usability through its integration with Electronic Health Records (EHRs) and the use of natural language processing for patient record interaction via Carebricks Chat. This allows for a more flexible and adaptable user experience across diverse clinical workflows. While Tool B has an intuitive interface for cath lab procedures, Tool A's approach provides more general applicability within a health system.

Clinical Value

FFRangio System

Tool B, the FFRangio System, provides immediate and critical clinical value by offering wire-free and drug-free 3D FFR guidance during PCI procedures, directly optimizing treatment decisions. Its demonstrated diagnostic accuracy of 93% and comparable clinical outcomes to invasive FFR in studies highlight its direct impact on patient care during intervention. While Tool A offers valuable opportunistic detection, Tool B's impact is more definitive in guiding real-time interventional treatment.

Pricing & Value

Bunkerhill AVC

Both tools require direct contact for pricing, limiting transparency. However, Tool A explicitly states it is HIPAA compliant and provides a Business Associate Agreement (BAA), which are critical assurances for healthcare organizations regarding data security and regulatory adherence. This clear compliance adds significant value for potential adopters, whereas Tool B's HIPAA compliance is noted as 'unknown' but 'likely'.

Enterprise Readiness

Bunkerhill AVC

Tool A demonstrates stronger enterprise readiness due to its deep integration capabilities with full Electronic Health Records (EHRs) and clinical archives across health systems. Its explicit HIPAA compliance and BAA further support its suitability for system-wide deployment and robust data governance. Tool B's deployment is more specialized, integrating with cath lab equipment, which limits its broader enterprise applicability.

Innovation

Bunkerhill AVC

Tool A stands out with its use of a 'generative AI platform, Carebricks, for clinical reasoning and action' and 'natural language processing for patient record interaction (Carebricks Chat)'. This represents a more advanced and broadly applicable innovation in AI technology for healthcare, aiming to transform a wider range of clinical workflows. While Tool B offers significant innovation in making FFR assessment less invasive, Tool A's generative AI approach is a more cutting-edge and versatile application of AI.

Support & Docs

FFRangio System

Tool B explicitly references the availability of 'Instructions For Use (IFU)' and an 'operator manual' for its system, indicating direct and structured documentation for users. While Tool A's Trust Center outlines robust internal security and operational procedures, explicit user-facing support channels or documentation were not detailed in the provided information or search results.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Bunkerhill AVC	FFRangio System
Name	Bunkerhill AVC	FFRangio System
Company	BunkerHill Health	CathWorks
Tagline	Generative AI for clinical reasoning and action.	A New Era in Coronary Physiology
Description	Bunkerhill Health provides a generative AI platform, Carebricks, for clinical reasoning and action, integrating with EHRs to automate workflows and improve patient outcomes. Its FDA-cleared algorithm, Bunkerhill AVC, specifically aids in the early detection and quantification of aortic valve calcification from chest CTs.	The CathWorks FFRangio System delivers wire-free and drug-free 3D FFR guidance, providing accurate multi-vessel FFR results and advanced insights to quickly optimize and confirm PCI decisions for patients with coronary artery disease.
Key Features	Generative AI for clinical reasoning and action, Automated detection and quantification of aortic valve calcification (Bunkerhill AVC), Automated detection and quantification of coronary artery calcification (iCAC, Contrast CAC), Automated detection and quantification of mitral annular calcification (Bunkerhill MAC), Opportunistic bone density assessment (Bunkerhill BMD), Integration with Electronic Health Records (EHRs) and clinical archives, Customizable AI agents for diverse workflows, Natural language processing for patient record interaction (Carebricks Chat)	Real-time FFRangio values at every point on the coronary tree, Simulated pullback curve differentiates functional patterns of CAD, Lesion Impact feature to assess residual ischemia, Integrated sizing tool for non-invasive lesion measurements, Intuitive user interface, Artificial intelligence aids in quick angiogram analysis, Seamless integration with cath lab boom and PACS, Eliminates the need for invasive pressure wires, drugs, or a guide catheter

Videos

Demos, reviews, and walkthroughs featuring Bunkerhill AVC and FFRangio System.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What are the primary clinical applications of each tool?

Bunkerhill AVC focuses on the early detection and quantification of aortic valve calcification, coronary artery calcification, mitral annular calcification, and opportunistic bone density assessment from chest CTs. The FFRangio System provides wire-free and drug-free 3D FFR guidance to optimize and confirm PCI decisions for patients with coronary artery disease.

How do these tools integrate into existing clinical workflows?

Bunkerhill AVC integrates with full Electronic Health Records (EHRs) and clinical archives within health systems, allowing for automated workflows and care coordination. The FFRangio System is deployed on-premise and integrates seamlessly with cath lab equipment, C-arm angiography systems, and PACS.

What type of imaging data does each tool utilize?

Bunkerhill AVC primarily analyzes non-gated, non-contrast, and contrast-enhanced chest CT images for calcification detection and quantification. The FFRangio System utilizes routine angiograms (X-rays) acquired during a diagnostic angiogram procedure to generate 3D FFR guidance.

How do these tools address patient data privacy and security?

Bunkerhill Health states that its platform is HIPAA compliant and has a Business Associate Agreement (BAA). The FFRangio System handles protected health information (PHI) and is ISO 27001 certified for information security, with a BAA likely, though not explicitly stated as HIPAA compliant on its public website.

What are the core technological approaches of each tool?

Bunkerhill AVC leverages generative AI for clinical reasoning and action, including natural language processing (NLP) for patient record interaction, and automated detection and quantification algorithms. The FFRangio System combines artificial intelligence and advanced computational science to obtain physiologic information from routine diagnostic angiograms, eliminating the need for invasive pressure wires or drug stimulation.

Can these tools assist in different stages of cardiac patient management?

Bunkerhill AVC focuses on early detection and risk stratification from routine CT scans, aiding in identifying at-risk patients for conditions like aortic stenosis and coronary artery disease. The FFRangio System provides real-time decision support during interventional cardiology procedures to optimize and confirm PCI decisions.